ストックスクリーナーアプリを入手
28.75
2.64%
-0.78
プレマーケット:
28.51
-0.24
-0.83%
前日終値:
$29.53
開ける：
$29.31
24時間の取引高:
919.71K
Relative Volume:
1.40
時価総額：
$1.65B
収益：
$681.88M
当期純損益:
$122.63M
株価収益率:
13.63
EPS:
2.11
ネットキャッシュフロー:
$220.18M
1週間 パフォーマンス:
+2.20%
1か月 パフォーマンス:
-12.13%
6か月 パフォーマンス:
-19.01%
1年 パフォーマンス:
-2.61%
1日の値動き範囲:
$27.71
$29.59
1週間の範囲:
$26.47
$29.67
52週間の値動き範囲:
$26.47
$41.61
Harmony Biosciences Holdings Inc Stock (HRMY) Company Profile
名前
Harmony Biosciences Holdings Inc
セクター
電話
(484) 539-9800
住所
630 W GERMANTOWN PIKE, PLYMOUTH MEETING
HRMY を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
HRMY
Harmony Biosciences Holdings Inc
|
28.75 | 1.65B | 681.88M | 122.63M | 220.18M | 2.11 |
|
VRTX
Vertex Pharmaceuticals Inc
|
500.49 | 128.67B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
557.91 | 60.99B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
605.38 | 36.92B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
230.93 | 29.89B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
238.84 | 25.73B | 3.81B | -644.79M | -669.77M | -6.24 |
Harmony Biosciences Holdings Inc Stock (HRMY) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-02-11 | 開始されました | Deutsche Bank | Buy |
| 2024-12-17 | 開始されました | H.C. Wainwright | Buy |
| 2024-10-10 | 再開されました | Raymond James | Outperform |
| 2024-09-10 | 開始されました | UBS | Buy |
| 2024-06-21 | 開始されました | Citigroup | Buy |
| 2024-01-02 | ダウングレード | BofA Securities | Neutral → Underperform |
| 2023-09-25 | ダウングレード | Goldman | Neutral → Sell |
| 2023-09-07 | 開始されました | Berenberg | Buy |
| 2023-04-20 | 開始されました | BofA Securities | Neutral |
| 2022-10-14 | アップグレード | Janney | Neutral → Buy |
| 2022-10-14 | アップグレード | Jefferies | Hold → Buy |
| 2022-08-03 | ダウングレード | Jefferies | Buy → Hold |
| 2022-07-13 | ダウングレード | Goldman | Buy → Neutral |
| 2022-07-07 | 開始されました | Mizuho | Buy |
| 2022-04-14 | 開始されました | Cantor Fitzgerald | Overweight |
| 2021-12-01 | 開始されました | Oppenheimer | Outperform |
| 2021-11-04 | 開始されました | Raymond James | Outperform |
| 2021-09-23 | 開始されました | Needham | Buy |
| 2021-03-29 | アップグレード | Goldman | Neutral → Buy |
| 2020-09-14 | 開始されました | Goldman | Neutral |
| 2020-09-14 | 開始されました | Jefferies | Buy |
| 2020-09-14 | 開始されました | Piper Sandler | Overweight |
すべてを表示
Harmony Biosciences Holdings Inc (HRMY) 最新ニュース
Franklin Resources Inc. Has $1.10 Million Stock Position in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) - Defense World
Harmony Biosciences Presents Positive Data on ZYN002 for Fragile X Syndrome - MyChesCo
Harmony Biosciences Appoints Ron Philip to Board of Directors - MSN
Harmony Biosciences (NASDAQ:HRMY) Earns “Buy” Rating from HC Wainwright - Defense World
Breaking Down Harmony Biosciences Hldgs: 13 Analysts Share Their Views - Benzinga
Harmony Biosciences Presents Promising Open-Label Extension Data of ZYN002 in Fragile X Syndrome - BioSpace
Oppenheimer maintains Harmony Biosciences Outperform rating By Investing.com - Investing.com UK
Developmental and Epileptic Encephalopathies Market to Observe Stunning Growth During the Study Period (2020–2034) | DelveInsight - GlobeNewswire Inc.
Oppenheimer on Harmony Biosciences (HRMY): 'we remain pleased with WAKIX's 4Q24 performance' - StreetInsider
Bronstein, Gewirtz & Grossman, LLC Is Investigating Harmony Biosciences Holdings, Inc. (HRMY) And Encourages Shareholders to Connect - markets.businessinsider.com
Harmony Biosciences reports progress in Fragile X syndrome gel treatment - Investing.com
Breakthrough: New Fragile X Treatment Achieves 73% Success Rate in Long-term Study - Stock Titan
HRMY stock touches 52-week low at $27.87 amid market shifts By Investing.com - Investing.com South Africa
HRMY stock touches 52-week low at $27.87 amid market shifts - Investing.com
Corebridge Financial Inc. Raises Stock Holdings in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) - Defense World
Vanguard Group Inc. Has $162.88 Million Stock Holdings in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) - The AM Reporter
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Stock Holdings Increased by Vanguard Group Inc. - Defense World
Arrowstreet Capital Limited Partnership Has $10.21 Million Stock Position in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) - The AM Reporter
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Given Average Rating of “Buy” by Analysts - The AM Reporter
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Given Consensus Recommendation of “Buy” by Analysts - Defense World
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Harmony Biosciences Holdings, Inc. (HRMY) and Encourages Shareholders to Learn More About the Investigation - ACCESS Newswire
Harmony Biosciences Holdings, Inc. (HRMY) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - markets.businessinsider.com
Harmony Biosciences Holdings, Inc. (HRMY): A Bull Case Theory - Insider Monkey
Harmony Biosciences Appoints Ron Philip to Board - TipRanks
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Harmony Biosciences Holdings, Inc. (HRMY) and Encourages Investors to Learn More About the Investigation - markets.businessinsider.com
Harmony Biosciences Appoints Ron Philip To Board - citybiz
Harmony Biosciences expands board with new director - Investing.com India
Harmony Biosciences Appoints Biotech Leader Ron Philip To Its Board Of Directors - MarketScreener
Harmony Biosciences expands board with new director By Investing.com - Investing.com UK
Harmony Biosciences Appoints Biotech Leader Ron Philip to Its Board of Directors - Business Wire
Strategic Win: Harmony Biosciences Taps Gene Therapy Pioneer Ron Philip for Board Role - Stock Titan
Raymond James Financial Inc. Invests $1.30 Million in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) - Defense World
Harmony Biosciences Holdings, Inc. (HRMY) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - markets.businessinsider.com
Thrivent Financial for Lutherans Acquires 5,880 Shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) - Defense World
Bronstein, Gewirtz & Grossman, LLC Is Investigating Harmony Biosciences Holdings, Inc. (HRMY) And Encourages Investors to Connect - markets.businessinsider.com
Teacher Retirement System of Texas Purchases 3,964 Shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) - Defense World
HighTower Advisors LLC Has $392,000 Stake in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) - Defense World
Bronstein, Gewirtz & Grossman, LLC Encourages Harmony Biosciences Holdings, Inc. (HRMY) Stockholders to Inquire about Securities Investigation - markets.businessinsider.com
Harmony Biosciences to Present at 24th Annual Needham Virtual Healthcare Conference - MyChesCo
Harmony Biosciences Names Adam Zaeske as Chief Commercial Officer - MyChesCo
Quantbot Technologies LP Grows Position in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) - Defense World
Bronstein, Gewirtz & Grossman, LLC Is Investigating Harmony Biosciences Holdings, Inc. (HRMY) And Encourages Stockholders to Connect - Markets Insider
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Shares Acquired by Swiss National Bank - Defense World
Harmony Biosciences (NASDAQ:HRMY) Stock Price Down 3.2%What's Next? - MarketBeat
Harmony Biosciences Holdings, Inc. (HRMY) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation - Markets Insider
Is Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) the Best Small Cap Stock to Buy Before They Explode? - Insider Monkey
10 Best Small-Cap Stocks to Buy Before They Explode - Insider Monkey
Harmony Biosciences appoints Adam Zaeske as Chief Commercial Officer - MSN
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Harmony Biosciences Holdings, Inc. (HRMY) and Encourages Stockholders to Learn More About the Investigation - Markets Insider
Harmony Biosciences to Participate in 24th Annual Needham Virtual Healthcare Conference - Yahoo
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Shares Acquired by PNC Financial Services Group Inc. - Defense World
Harmony Biosciences Holdings Inc (HRMY) 財務データ
収益
当期純利益
現金流量
EPS
0.98%
5.78%
大文字化:
|
ボリューム (24 時間):